INTRODUCTION .
Since the first descriptions of pediatric AIDS a decade a large body of information has accumulated on the mother to child transmission of HIV type 1, its natural history and the clinical expression of HIV infection in ~hildren.~-ll However, few data are available on the anthropometric characteristics of HIVinfected children,12-15 particularly in sub-Saharan Africa where the majority of pediatric AIDS cases occur.
From 1988 to 1994 a prospective cohort study on the perinatal transmission of HIV has been performed in Kigali, the capital of We report on the anthropometric findings collected during the first 4 years of life on children born to HIV-infected and uninfected mothers.
METHODS
Details about enrollment and follow-up procedures in the cohort have been described elsewhere. 16 Briefly 218 infants born to 215 HIV-seropositive mothers were enrolled at birth between November, 1988, and June, 1989 , at the maternity ward of the Centre Hospitalier de Kigali. These children were matched with 218 children born to HIV-seronegative mother
The children and their mothers were age and parity. 4 weeks thereafter. They were either visited at home by a social worker or attended the outpatient clinic organized within the Mother and Child Health Clinic of the Centre Hospitalier de Kigali. In addition the children were systematically examined by a physician every 3 months during the first year of life and eveiy 6 months thereafter. When necessary children were seen in the outpatient department or hospitalized in the Department of Pediatrics and treated free of charge. All the children were immunized during the first 15 months of life following the recommendations of the World Health Organization Expanded Programme of Immunization with one exception; a high dose Edmonston-Zagreb measles vaccine was given at 6 months of age in the place of the Schwarz vaccine at 9 months.1' The phyworkers were blinded to the HN infection status of the children to 18 months of age.
Definitions of pediatric HW infection and c.assification of the children. Criteria used to define children born to seropositive mothers as infected with HIV, uninfected or with an indeterminate status were drawn from a Working Group Consensus on Motherto-Child Transmission of HN-L8 This classification takes into account the HIV antibody serostatus at 15 months of age and, when the child died before this age, the presence or absence of signs and symptoms possibly related either (1) in a child fulfilling the WHO clinical case definition of pediatric AIDS (in which severe and/or recurrent pulmonary infection was considered sign)lg9 2o or (2) in a child with at least one HIV-related infection or persistent diarrhea (214 days) beyond the were regarded as HIV-related: persistent diarrhea; failure to thrive (< 80% weight for age); generalized 'wphadenopathy (lymph nodes measuring at least cm and present in two or more extrainguinal sites); oral candidiasis (beyond the neonatal period); severe or recurrent Pneumonia; Chronic Parotitis and herpes zoster infection (shingles).
The children born to HIV-seropositive mothers were considered as HN-infected (Group 1) (1) if they presented clinical manifestations of AIDS at any time during the follow-up, (2) if they were positive for HIV antibody at 15 months of age or (3) if they died before 15 months of age and their death was considered HIV-related. They were considered as HIV-uninfected Ô r seroreqeders (Group 2) if (1) they were negative for ibOdY at 15 months or (2) if they died before , they were HIV-seronegative and their death robably undated to HIV. Children born to HIVe mothers who were lost to follow-up before of age were considered uninfected when the Fig. 1 ) and except at 36 months of age for the H-A mean z score (Fig. 2) ). The difference in the HC-A mean z scores between Group 1 and Group 3 children was statistically significant (P < 0.017) during the first 2 years of life (except at birth, 12 and 18 months of age (Fig. 3) ). The reduction in the W-A mean z score was already noticeable at 3 months of age but was the greatest (below 2 SD) between 12 and 36 months of age (Fig. 1 ). The reduction in the H-A mean z score of HIV-infected children was also manifest at 3 months of age, with a decrease below 2 SD from 9 to 48 months of age (Fig. 2) . Moreover the HC-A mean z score of HIV-infected children was below 1 SDSD from 18 to 36 months of age (Fig. 3) .
On the other hand the W-H mean z score was rarely lower in HIT-infected children than in uninfected ones, the difference being only statistically significant (P < 0.017 for Group 1 us. Group 3) at ages 3, 6,24 and 36 months (Fig. 4) . The W-H mean z score of HIV-infected children was not frequently impaired according to international standards.
Although often low in comparison to international standards, the W-A, H-A and HC-A mean z scores of HIV-uninfected-children born to seropositive (Group 2) and those born to seronegative mothers (Group 3) were comparable (Figs. 1 to 3) . Indeed statistically significant differences for W-A, H-A and HC-A mean z scores (P < 0.017 for Group 2 us. Group 3) were not observed during the first 48 months of life between these two groups except at 6 months of age for the H-A mean z score (Fig. 2) .
h m g the HIV-infected children who survived until 48 months of age, there was a decline of the W-A mean z score until 36 
FIG.
3. Mean head circumference-for-age z score in HIV-l-infected and uninfected children, Kigali (Rwanda), 1989 to 1993. GI, HIV-infected children; G2, uninfected children born to seropositive mothers; G3, uninfected children born to seronegative mothers.
mothers and observed diminished stature and weight gain in HIV-infected children when they were compared to seroreverters. However, two-thirds of the HIV-infected children included in their study were referred for antiretroviral therapy after 3 months of age; therefore the design of this study was not optimal to evaluate the general impact of HIV on the nutritional status of young HIV-infected children. In the European Collaborative Study15 HN-infected children were shorter and weighed less than their uninfected counterparts. Although statistically significant, the difference between infected and uninfected children was small in this study.15 Until now follow-up studies of anthropometric measurements of African HIV-infected children were lacking. Our prospective cohort study of Rwandan children born to HIV-infected and uninfected mothers followed from birth until 48 months of age demonstrates an early, severe and sustained impairment in weight, height and head circumference gain among HIVinfected children when compared with uninfected ones of the same age, birth order and socioeconomic status. None of these African HIV-infected children received zidovudine. Indeed antiretroviral treatment has a positive impact on weight growth rate^.'^ On the other hand the W-H mean z scores of HN-infected children from this study were generally comparable to the figures obtained with uninfected ones or to international standards. The same findings were observed in North American children'' as well as among perinatally HIV-l-infected school age children in Rwanda.28
A cross-sectional study of malnourished children with an HIV-1 seroprevalence of 14% in Butare, Rwanda, also showed that seropositivity was found more frequently among children with low W-A and H-A than among those with low W-H. 29 The pathogenesis of malnutrition in HIV-1 infection is poorly understood and the respective roles of infections, endocrinologic dysfunctions and the possibility of an increased resting energy expenditure in infected patients remain to be delineated?8s [30] [31] [32] In this study low W-A and low H-A occurred only in HIV-l-idected children with a history of severe á d o r persistent infectious illnesses such as persistent diarrhea, chronic fever and pneumonia (data not shown), strongly suggesting that infections were an important cause of poorer growth in these infected children. Larger numbers of HIV-1-infected children are needed to confirm the stabilization of the growth measurements observed between 24 and 48 months of age in this study. Moreover, more detailed nutritional studies should be undertaken to determine the mechanisms of malnutrition in these HIV-1-infected children. Until 36 months of age the HC-A mean z scores of the HIV-1-infected children were lower than those of uninfected ones in this study. This is consistent with the demonstrated neurotropic characteristics of HIV-l.33 HIV-infected children from this cohort have previously been shown to be more frequently developmentally delayed than HIV-uninfected children during the first 2 years of life, although no case of encephalopathy has been observed during this period. 34 This study emphasizes the importance of the comparison groups of uninfected children of the same socioeconomic, .obstetrical and genetic background for the interpretátion of anthropometric indices and their evolution over time. In this study uninfected children born to seropositive mothers had the same W-A, H-A and HC-A mean z scores than those born to seronegative mothers. We have already shown that uninfected children born to seropositive mothers had the same neonatal characteristics and the same neurodevelopmental testing than those born to seronegative mothe r~.~~'~~ In contrast we have now demonstrated that these uninfected children are frequently thin and small in comparison to international standards.
In conclusion this study shows that Rwandan HIV-1-infected children ages O to 48 months old are frequently undernourished (low W-A) and stunted (low H-A), but not wasted (low W-HI, compared with uninfected children. Uninfected children born to HIV-1-seropositive mothers and those born to seronegative mothers have the same anthropometric characteristics. Recent cro~s-sectional~~ and 10ngitudinal~~ data from Zaire have shown that diarrhea was strongly associated with severe malnutrition and HIV-1 infection. Therefore it remains to be demonstrated whether early nutritional interventions in those children with stunting and low W-A have an impact on the survival of African HIV-1-infected children.
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